Latest filing published 05 Jun 2026 for Sanara MedTech Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Robert Andrew DeSutter: trading record in brief
Robert Andrew DeSutter (board member) discloses dealings in Sanara MedTech Inc. to SEC (Form 4). The record holds 7 filings, for trades running from 9 February 2022 to 4 June 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 5 June 2026: a share grant, in Sanara MedTech Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Robert Andrew DeSutter
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,539 shares0Common StockSEC:0001493152-26-027586:0
- 3,746 shares0Common StockSEC:0001641172-25-012543:0
- 3,932 shares0Common StockSEC:0001493152-24-023959:0
- 2,936 shares0Common StockSEC:0001493152-23-020182:0
- 5,256 shares0Common StockSEC:0001493152-22-018958:0
- 4,887 shares0Common StockSEC:0001493152-22-004097:0
6 of 6 declarations
